Although prudent on the surface, Altria's attempts to diversify from cigarettes have fallen flat. Its $1.8 billion investment into Canada cannabis licensed producer Cronos for a 41% stake and a $12.8 ...

The clinical studies will aim to support an FDA 510(k) submission to obtain clearance ... and spend more time with patients. By leveraging OCI, NYGH is positioning itself to advance innovation ...

The clinical studies will aim to support an FDA 510(k) submission to obtain clearance ... record system to Oracle Cloud Infrastructure (OCI). The move has significantly decreased system latency ...

The clinical studies will aim to support an FDA 510(k) submission to obtain clearance ... record system to Oracle Cloud Infrastructure (OCI). The move has significantly decreased system latency ...

This is Part I of a two-part story exploring mental health and well-being in the legal community with first, exploring issues ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announced that the Company will hold a conference call on Tuesday, May 13, 2025, at 2 p.m. CEST / 8 a.m. EDT, to ...

Adjusted OCI margins were 64.4% ... But more importantly is exactly where you went, which is the FDA and the CTP. Did they take seriously the regulatory act that was passed by Congress?

They severely limit FDA-authorized choices for consumers and ... The smokeable products segment grew adjusted operating company's income or OCI by 2.7%. Adjusted OCI margins were 64.4, an increase ...